61 related articles for article (PubMed ID: 25014136)
21. [Identification of differentially expressed genes of acute hypoxia-treated HepG2 cells and hypoxia-acclimatized HepG2 cells].
Wang JH; Shan YJ; Cong YW; Wu LJ; Yuan XL; Zhao ZH; Wang SQ; Chen JP
Sheng Li Xue Bao; 2003 Jun; 55(3):324-30. PubMed ID: 12817301
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of mRNA-seq and miRNA-seq in the liver of Pelteobagrus vachelli in response to hypoxia.
Zhang G; Yin S; Mao J; Liang F; Zhao C; Li P; Zhou G; Chen S; Tang Z
Sci Rep; 2016 Mar; 6():22907. PubMed ID: 26961594
[TBL] [Abstract][Full Text] [Related]
23. Dramatic down-regulation of oxidoreductases in human hepatocellular carcinoma hepG2 cells: proteomics and gene ontology unveiling new frontiers in cancer enzymology.
Ngoka LC
Proteome Sci; 2008 Oct; 6():29. PubMed ID: 18950483
[TBL] [Abstract][Full Text] [Related]
24. Editorial: Tumorigenesis regulated by miRNAs, Volume II.
Liu T; Li G; Ye W
Front Mol Biosci; 2023; 10():1264564. PubMed ID: 37621996
[No Abstract] [Full Text] [Related]
25. RNA-Seq gene expression profiling of HepG2 cells: the influence of experimental factors and comparison with liver tissue.
Tyakht AV; Ilina EN; Alexeev DG; Ischenko DS; Gorbachev AY; Semashko TA; Larin AK; Selezneva OV; Kostryukova ES; Karalkin PA; Vakhrushev IV; Kurbatov LK; Archakov AI; Govorun VM
BMC Genomics; 2014 Dec; 15(1):1108. PubMed ID: 25511409
[TBL] [Abstract][Full Text] [Related]
26. Regulatory Role of microRNAs Targeting the Transcription Co-Factor ZNF521 in Normal Tissues and Cancers.
Chiarella E; Aloisio A; Scicchitano S; Bond HM; Mesuraca M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445164
[TBL] [Abstract][Full Text] [Related]
27. Synergistic Effect of MC-LR and C-Terminal Truncated HBx on HepG2 Cells and Their Effects on PP2A Mediated Downstream Target of MAPK Signaling Pathway.
Xiao C; Mei F; Ren G; Long L; Chen M; Fang X; Li J; Li K; Tang Y; Huang T; Deng W
Front Genet; 2020; 11():537785. PubMed ID: 33193609
[TBL] [Abstract][Full Text] [Related]
28. Behavioral Changes in Stem-Cell Potency by HepG2-Exhausted Medium.
Balzano F; Garroni G; Cruciani S; Bellu E; Dei Giudici S; Oggiano A; Capobianco G; Dessole S; Ventura C; Maioli M
Cells; 2020 Aug; 9(8):. PubMed ID: 32806709
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1.
Dong K; Du Q; Cui X; Wan P; Kaltenmeier C; Luo J; Yan B; Yan Y; Geller DA
Biochem Biophys Res Commun; 2020 Apr; 524(2):273-279. PubMed ID: 31987500
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance.
Liu WB; Jia WD; Ma JL; Xu GL; Zhou HC; Peng Y; Wang W
Oncotarget; 2017 Nov; 8(55):93984-93997. PubMed ID: 29212203
[TBL] [Abstract][Full Text] [Related]
31.
Ashida R; Okamura Y; Ohshima K; Kakuda Y; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Sugino T; Urakami K; Kusuhara M; Yamaguchi K
Cancer Genomics Proteomics; 2017; 14(6):445-453. PubMed ID: 29109094
[TBL] [Abstract][Full Text] [Related]
32. New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease.
López-Riera M; Conde I; Tolosa L; Zaragoza Á; Castell JV; Gómez-Lechón MJ; Jover R
Front Pharmacol; 2017; 8():3. PubMed ID: 28179883
[No Abstract] [Full Text] [Related]
33. Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma.
Ranganathan S; Ningappa M; Ashokkumar C; Higgs BW; Min J; Sun Q; Schmitt L; Subramaniam S; Hakonarson H; Sindhi R
Sci Rep; 2016 Dec; 6():38347. PubMed ID: 27910913
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells.
Yan Y; Liang Z; Du Q; Yang M; Geller DA
Oncol Rep; 2016 Aug; 36(2):633-40. PubMed ID: 27279136
[TBL] [Abstract][Full Text] [Related]
35. The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles.
Bai Y; Xue Y; Xie X; Yu T; Zhu Y; Ge Q; Lu Z
Gene; 2014 Sep; 548(1):91-100. PubMed ID: 25014136
[TBL] [Abstract][Full Text] [Related]
36. Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity.
Song MK; Lee HS; Ryu JC
Toxicology; 2015 Aug; 334():111-21. PubMed ID: 26079696
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin.
Yang Y; Liu W; Ding R; Xiong L; Dou R; Zhang Y; Guo Z
PLoS One; 2016; 11(2):e0149227. PubMed ID: 26886852
[TBL] [Abstract][Full Text] [Related]
39. A microRNA gene signature for identification of lung cancer.
Xue Z; Wen J; Chu X; Xue X
Surg Oncol; 2014 Sep; 23(3):126-31. PubMed ID: 25031224
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide analysis of microRNA and mRNA expression signatures in cancer.
Li MH; Fu SB; Xiao HS
Acta Pharmacol Sin; 2015 Oct; 36(10):1200-11. PubMed ID: 26299954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
